Elizabeth Cooney

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular therapy.

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and maternity care.

Experts in heart health, nutrition, epidemiology, and more on what to expect from the Trump White House.

“This study really gets me very excited because it just basically says, my God, if you're exposed in utero to sugar, years later you develop more diabetes," an endocrinologist said.

To study potential harm of ultra-processed foods, randomized trials have to be very large and very long to get answers about prevention of chronic diseases.

Why, despite mounting evidence about harms of ultra-processed foods, do dietary guidelines appear unlikely to change much? Experts assess the advisory panel.

An advisory panel on dietary guidelines says the American diet is flawed but more data is needed to take action on ultra-processed foods or alcohol.

Experts advising on dietary guidelines say it's premature to tackle ultra-processed foods. "In the next five years, research is going to explode."

At the STAT summit, executives discuss their challenges, and hopeful signals, about breaking into markets on obesity and Alzheimer's.

Alnylam's Yvonne Greenstreet, at #STATSummit, predicts vutrisiran will become multibillion-dollar product for ATTR-cardiomyopathy, despite increasing competition.